Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Whilst Mounjaro has demonstrated significant efficacy in glycaemic control and weight reduction in clinical trials, gastrointestinal side effects are amongst the most commonly reported adverse reactions
The LEADER trial provided landmark evidence that liraglutide reduces cardiovascular death and major adverse cardiovascular events in patients with type 2 diabetes
[12] [13] However, it's important to note that FAERS data cannot establish incidence rates or causality due to voluntary reporting, potential reporting bias, and lack of denominator data
May be suitable for those already managing type 2 diabetes, as Rybelsus is FDA-approved for diabetes treatment and may help with weight loss in these individuals
Most patients experience mild or no side effects at this dose
US$ 29.17
US$ 29.78
US$ 26.97
US$ 29.23
